Evidence map›Paper›PMID 30061198›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2018

The Phagocyte Oxidase Controls Tolerance to

Andrew J Olive, Clare M Smith, Michael C Kiritsy, Christopher M Sassetti

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. HowVaccines · 2026
    Review
  5. Review
  6. Sorting nexin 5 mediates antigen presentation and immunity againstbioRxiv : the preprint server for biology · 2026
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. High Lethality ofInfection and immunity · 2023
    Article
  14. Article
  15. International journal of molecular sciences · 2023
    Article
  16. Animal models for COVID-19 and tuberculosis.Frontiers in immunology · 2023
    Review
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Andrew J OliveUniversity of Massachusetts Medical School, Worcester, MA 01605.ORCID 0000-0003-3441-3113
Clare M SmithUniversity of Massachusetts Medical School, Worcester, MA 01605.ORCID 0000-0003-2601-0955
Michael C KiritsyUniversity of Massachusetts Medical School, Worcester, MA 01605.ORCID 0000-0001-8364-8088
Christopher M SassettiUniversity of Massachusetts Medical School, Worcester, MA 01605 Christopher.Sassetti@umassmed.edu.
University of Massachusetts Chan Medical School · US

Funding

Systems Genetics of TuberculosisP01AI132130 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI BEHAR, SAMUEL M · 2017 to 2021
$11.2M
Tuberculosis Pathogenesis and Drug ResponseR01AI064282 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI SASSETTI, CHRISTOPHER M · 2007 to 2017
$3.9M
Innate Immunity Training ProgramT32AI095213 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI SILVERMAN, NEAL · 2011 to 2025
$2.5M
NIAID NIH HHS P01 AI132130NIAID NIH HHS R01 AI064282NIAID NIH HHS T32 AI095213
6 · The paper itself

Abstract

Protection from infectious disease relies on two distinct strategies: antimicrobial resistance directly inhibits pathogen growth, whereas infection tolerance protects from the negative impact of infection on host health. A single immune mediator can differentially contribute to these strategies in distinct contexts, confounding our understanding of protection to different pathogens. For example, the NADPH-dependent phagocyte oxidase (Phox) complex produces antimicrobial superoxide and protects from tuberculosis (TB) in humans. However, Phox-deficient mice display no sustained resistance defects to

Indexed as

Immunity, InnateNeutrophil InfiltrationAnimalsCaspase 1Enzyme ActivationHumansInterleukin-1betaLungMiceMice, KnockoutMycobacterium tuberculosisNADPH Oxidase 2NeutrophilsTuberculosis, PulmonaryCaspase 1Cybb protein, mouseIL1B protein, mouseInterleukin-1betaNADPH Oxidase 2

Identifiers

PMID30061198
PMCPMC6125170
OpenAlexW2783898835

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.